metricas
covid
Neurología (English Edition) Paraneoplastic cerebellar degeneration and anti-Yo antibodies
Journal Information
Vol. 26. Issue 5.
Pages e3-e4 (January 2011)
Vol. 26. Issue 5.
Pages e3-e4 (January 2011)
Full text access
Paraneoplastic cerebellar degeneration and anti-Yo antibodies
Degeneración cerebelosa paraneoplásica y anticuerpos anti-Yo
Visits
2323
L. Batallera,b,
Corresponding author
l_bataller@yahoo.com

Corresponding author.
, E. Fagesc,e, C. Alberolad
a Servicio de Neurología, Hospital Universitario La Fe, Valencia, Spain
b Laboratorio de Neurología Experimental, Centro de Investigación, Hospital Universitario La Fe; Valencia, Spain and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED)
c Servicio de Neurología, Hospital Santa Maria del Rosell, Cartagena, Murcia, Spain
d Servicio de Anatomía Patológica, Hospital Universitario La Fe, Valencia, Spain
e E. Fages was working at the Servicio de Neurología, Hospital Universitario la Fe, Valencia, Spain, when this paper was written
This item has received
Article information
Full text is only available in PDF
References
[1.]
H.M. Furneaux, M.K. Rosenblum, J. Dalmau, E. Wong, P. Woodruff, F. Graus, et al.
Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration.
N Engl J Med, 322 (1990), pp. 1844-1851
[2.]
F. Graus, J.Y. Delattre, J.C. Antoine, J. Dalmau, B. Giometto, W. Grisold, et al.
Recommended diagnostic criteria for paraneoplastic neurological syndromes.
J Neurol Neurosurg Psychiatry, 75 (2004), pp. 1135-1140
[3.]
I. Rojas, F. Graus, F. Keime-Guibert, R. Reñé, J.Y. Delattre, J.M. Ramón, et al.
Long term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies.
Neurology, 55 (2000), pp. 713-715
Copyright © 2011. Sociedad Española de Neurología
Download PDF
Article options
Tools